CD19 bead positive selection was used to purify CLL cells and greater than 97% CLL cell purity was verified by FACS analysis of CD5 and CD19 expression for all samples used in this study (Figure S1). Here, CD5 is linked to B-cell chronic lymphocytic leukemia.